DrugPatentWatch Database Preview
« Back to Dashboard
Colistimethate Sodium is a drug marketed by Emcure Pharms Ltd, Fresenius Kabi Usa, Nexus Pharms, Sagent Pharms, X Gen Pharms, and Xellia Pharms Aps. and is included in six NDAs.
The generic ingredient in COLISTIMETHATE SODIUM is colistimethate sodium. There are two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the colistimethate sodium profile page.